Med-IQ

03/03/2026

New CME for Cardiovascular Clinicians!
LDLC management is changing, especially for high-risk primary prevention patients. Learn about the latest guidance for LDL-C lowering and new and emerging PCSK9 therapies (including novel oral options).

This complimentary, 30minute CME activity provides a concise, evidence-based update on treatment strategies for high-risk ASCVD patients, complete with faculty insights and real-world cases.

Earn 0.5 CME credit and stay ahead of what’s coming next in lipid management.

Join the activity: https://clinical.med-iq.com/activity/ldl-c-management-in-high-risk-ascvd-current-treatment-options-and-the-evolving-role-of-pcsk9-inhibitors?utm_source=fb&utm_medium=social&utm_campaign=me128-fb

03/03/2026

: Patient safety starts from the very first moment you enter the room. Positive entrances are just the start of safer care.

Hospitals and healthcare systems face tighter budgets, but clinician education remains critical.

That’s why Med-IQ is introducing budget-conscious options for risk management and patient safety programs. Our goal is to help you deliver high-quality, engaging, actionable learning without draining your team's time or resources.

Whether you’re reducing liability risk, improving outcomes, or strengthening safety culture, our tailored solutions make it easier—and more affordable—to achieve your goals.

Let’s talk about your priorities. Email Contact@med-iq.com or visit https://info.med-iq.com/acton/fs/blocks/showLandingPage/a/31318/p/p-0023/t/page/fm/0

02/26/2026

As February comes to a close, Med-IQ recognizes and celebrates on its 100th anniversary. We are grateful to the Black healthcare professionals who, in the face of systemic obstacles, work to improve the lives of their patients.

02/24/2026

: Misinformation is everywhere. In a survey of 2,100+ clinicians, 94% reported regularly encountering patients influenced by medical misinformation.

When decisions are guided by inaccurate sources, clinical outcomes and patient safety are at risk. HCPs have a responsibility and an opportunity to help patients discern fact from fiction.

Using empathetic, patient-centered communication—including strategies like the Three Cs—empowers patients to make informed decisions and protects their autonomy.

Hospitals and healthcare systems face tighter budgets, but clinician education remains critical.

That’s why Med-IQ is introducing budget-conscious options for risk management and patient safety programs. Our goal is to help you deliver high-quality, engaging, actionable learning without draining your team's time or resources.

Whether you’re reducing liability risk, improving outcomes, or strengthening safety culture, our tailored solutions make it easier—and more affordable—to achieve your goals.

Let’s talk about your 2026 priorities. Email Contact@med-iq.com or visit https://lnkd.in/eFmy33aJ

02/21/2026

Advance equity in IBD care with this CME‑accredited activity featuring experts Dr. Adjoa Anyane‑Yeboa and Dr. Ugo Iroku.
✔️ Understand disparities in IBD
✔️ Learn how implicit bias affects care
✔️ Get practical strategies to improve equity
Access now: https://clinical.med-iq.com/activity/toward-health-equity-in-ibd-combating-implicit-bias-in-ibd-care

02/20/2026

Explore how obesity affects transplant candidacy, evaluation strategies, and potential interventions to optimize patients for transplant. This interactive explores a case, then provides rationale for correct answers and key takeaways to support informed, patient-centered decision making.
https://clinical.med-iq.com/activity/obesity-in-kidney-transplantation-the-weight-of-the-matter?utm_source=fb&utm_medium=social&utm_campaign=dk106-kidney-fb

02/20/2026

This focused offering will arm you with the targeted insights and tools you need to identify “red flags,” ask the right questions, and empower patients and caregivers. MIQ-clinical.med-iq.com/activity/hcm-red-flags-what-clinicians-need-to-know?utm_source=fb&utm_medium=social&utm_campaign=bm189-fb

Navigate Complexity ⇒ Learn how to avoid common pitfalls and dig deeper with patients to prevent missed or delayed HCM diagnoses.

Update Practice ⇒ Review the most current management guidelines, including the introduction of the cardiac myosin inhibitor mavacamten for obstructive HCM.

Integrate the Latest Evidence ⇒ The 2024 HCM guideline updates reflect major advances. This course simplifies the key evidence and helps you translate new recommendations into everyday care.

In this accredited CME activity, internationally recognized hypertrophic cardiomyopathy (HCM) expert Dr. Matthew Martinez navigates the complexities of diagnosing HCM and explains when to dig deeper with patients to avoid misdiagnoses. He reviews guidelines for the management of HCM and provides pra...

02/19/2026

A 40-year-old woman with a 1 pack-year smoking history presents with right lower extremity pain with exertion. What will your next steps be in the management of this patient? In this activity, explore modifiable cardiovascular risk factors, sex-specific markers of risk, and management of diabetes in the presence of cardiovascular disease.

In this accredited CME activity meet a patient who presents with right lower extremity pain with exertion. What will your next steps be in the management of this patient? This activity will discuss modifiable cardiovascular risk factors, sex-specific markers of risk, and management of diabetes in th...

02/19/2026

The first 6 months are critical. Early detection of atypical motor patterns can transform a child’s developmental future.

This free accredited CME shows you how a simple, 30-second, 4-position observational exam can help:
• Identify motor delays before they’re missed
• Refer earlier
• Unlock neuroplasticity
• Give families a stronger path forward

Don’t overlook your role in early intervention. https://clinical.med-iq.com/activity/detecting-early-motor-delays-from-newborn-to-6-months?utm_source=fb&utm_medium=social&utm_campaign=py001-fb

02/18/2026

The latest trial results can help guide optimal and personalized treatment choices for patients. Join this brief activity for a focused update on emerging treatments, featuring key highlights and actionable insights from recent meetings.

This CME activity discusses updates in prostate cancer treatment and highlights key data from the AUA and ASCO 2025 annual meetings.?

02/18/2026

In this activity, expert faculty discusses optimal therapy for patients with , with a focus on the importance of considering referral to epilepsy centers, especially when seizures are not well controlled.

This accredited activity for primary care providers discusses optimal therapy for patients with epilepsy. Specifically, it focuses on the importance of considering referral to epilepsy centers, especially when seizures are not well controlled. This activity also aims to educate primary care provider...

02/17/2026

Although as many as 120,000 adults in the US may have ATTR-CM, delayed diagnosis remains a challenge due to symptom overlap and low clinical recognition. In this activity, equip yourself with the latest practical tools and evidence-based strategies you need for early detection and optimal management:

This CME activity discusses the diagnosis and treatment of ATTR-CM and highlights key updates on ATTR-CM treatment from the ACC 2025 annual meeting.